Hospital News
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- Lessons From Major Heart Trial Need Implementation
- The PARTNER Trial Shows Similar One-Year Survival for Catheter-Based Aortic Valve Replacement and Open Aortic Valve Replacement in High-Risk Patients
- Bariatric Surgery Reduces Long-Term Cardiovascular Risk in Diabetes Patients
- Barbara Walters Heart Health Special
- Blood Test to Predict Multi-Organ Dysfunction in Patients With LVADs on Horizon
- Gene Therapy Can Substantially Improve Outcomes for Some Patients With Advanced Heart Failure
- Cooling May Benefit Children After Cardiac Arrest
- Gene Expression Test Reduces Need for Invasive Heart Muscle Biopsy
- Women's Health Alert: Fighting Heart Disease in Your 40s
- Dr. Craig R. Smith Named Chair of Surgery and Surgeon-in-Chief at Columbia University Medical Center and NewYork-Presbyterian/Columbia
- Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education
- 100th Heart Valve Replacement Implanted Without Open-Heart Surgery at NewYork-Presbyterian/Columbia
- First Heart Patients Implanted With Next-Generation Mechanical Heart Pump
- NEJM Study Finds Drug-Eluting Stents More Effective Than Bare-Metal Stents in Heart Attack Patients
- Potential Lung Disease Biomarkers Yield Clues to COX-2 Inhibitor Side Effects
- Unique Cardiac Training Gives NewYork-Presbyterian/Columbia Doctor Ability to Treat Heart Patients With Hybrid Approach
Research and Clinical Trials
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
Clinical Services
Return to Heart Transplant Surgery Overview
More on Heart Transplant Surgery
- Adult Congenital Heart Disease
- Adult Congenital Heart Disease Surgery
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Arrhythmia Control
- Artificial Heart - Ventricular Assist Devices (VADs)
- Balloon Valvuloplasty for Heart Valve Disease
- Bridge to Transplant
- Cardiac Electrophysiologic Studies
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (CABG)
- Destination Therapy
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Attack Care
- Heart Attacks in Women
- Heart Valve Repair and Replacement
- Heart Valve Replacement Studies and Clinical Trials
- Heart Valve Treatments
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-Pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Prevention
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Risk Factors for Heart Attacks
- Robotic Heart Surgery
- Tilt Testing
- Transmyocardial Revascularization
- Treating a Heart Attack
- Treatment of Peripheral Arterial Disease
- Warning Signs
- What is Heart Failure?
Cardiothoracic Surgery
Heart Transplant Surgery
Back to the nypheart.org Home Page
Patients with end-stage heart failure who do not respond to medical treatment may be candidates for heart transplants. In heart transplant surgery, a patient's diseased heart is removed and replaced with a healthy, donated human heart. NewYork-Presbyterian Hospital has a distinguished history of advancing "standards of care" and the survival rates of our patients by using innovative surgical techniques, applying our basic scientific research in immunosuppression to the clinical setting, and inventing and perfecting life-sustaining cardiac assist devices that prolong life while waiting for organ availability. Surgeons at NewYork-Presbyterian have already performed more heart transplants – over 1700 – since 1977.
Every year, heart transplant surgery remains limited to the most severe cases. This is due, in part, to a shortage of donor hearts, which must pass through a stringent screening process. Moreover, the need for donated hearts goes beyond those on the transplant waiting list. There are many patients who — because of complicating health issues or age restrictions — are not eligible to be included on the transplant waiting list, yet are in need of a transplant.
In an attempt to address these problems, the heart transplant team at NewYork-Presbyterian Hospital recently launched the Alternative Heart Transplant Program, which expands the usual criteria by which donor hearts are accepted. If, after careful assessment by our transplant team, the donor heart’s function is found to be acceptable, the program tries to match the heart to a patient who would otherwise not be eligible for transplant.
Contact
- Cardiothoracic Surgery, NewYork-Presbyterian/Weill Cornell
-
Directions
(212) 746-5151
- Cardiothoracic Surgery, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-8312



